SCM
Silverarc Capital Management Portfolio holdings
AUM
$489M
This Quarter Return
+1.96%
1 Year Return
+71.55%
3 Year Return
+1,109.63%
5 Year Return
–
10 Year Return
–
AUM
$479M
AUM Growth
+$479M
(+7%)
Cap. Flow
+$61M
Cap. Flow
% of AUM
12.75%
Top 10 Holdings %
Top 10 Hldgs %
50.4%
Holding
82
New
23
Increased
27
Reduced
15
Closed
14
Top Buys
| 1 |
KalVista Pharmaceuticals
KALV
|
$12.5M |
| 2 |
Soleno Therapeutics
SLNO
|
$11.9M |
| 3 |
89bio
ETNB
|
$10.3M |
| 4 |
Neurocrine Biosciences
NBIX
|
$8.03M |
| 5 |
Disc Medicine
IRON
|
$6.26M |
Top Sells
| 1 |
Pliant Therapeutics
PLRX
|
$17.3M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$15M |
| 3 |
PSTX
Poseida Therapeutics, Inc. Common Stock
PSTX
|
$9.72M |
| 4 |
Scholar Rock
SRRK
|
$7.92M |
| 5 |
Cogent Biosciences
COGT
|
$7.18M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Cogent Biosciences
COGT
$1.68B
| – | – |
-921,137
| Closed | -$7.18M |
|
77
EyePoint Pharmaceuticals
EYPT
$797M
| – | – |
-121,274
| Closed | -$903K |
|
78
Geron
GERN
$938M
| – | – |
-920,022
| Closed | -$3.26M |
|
79
Incyte
INCY
$16.8B
| – | – |
-49,000
| Closed | -$3.38M |
|
80
Karyopharm Therapeutics
KPTI
$58.8M
| – | – |
-595,990
| Closed | -$403K |
|
81
Neumora Therapeutics
NMRA
$280M
| – | – |
0
| – | – |
|
82
Olema Pharmaceuticals
OLMA
$444M
| – | – |
-233,281
| Closed | -$1.36M |
|